Navigation Links
Wysebridge Patent Bar Review Launches America Invents Act (AIA) Study Suite
Date:4/26/2013

Philadelphia, PA (PRWEB) April 26, 2013

Wysebridge Patent Bar Review, the industry leader in providing detailed and personalized study materials for the Patent Bar Exam, has released the latest updates to their study materials online. Included in these materials, are comprehensive and focused guides outlining and explaining the changes to patent law with the passage of the America Invents Act (AIA) and the impact on the USPTO patent bar exam, which went into effect on April 2nd. The United States Patent and Trademark Office (USPTO) patent bar exam is the nationally administered examination that is required of anyone seeking to become a patent attorney or patent agent.

Test takers across the country have been growing more and more concerned over the changes that went into place on April 2nd on the patent bar exam involving the AIA updates. Adding more confusion and frustration to the mix, the USPTO has limited the freedom by which test-takers can discuss the information seen and known about the exam. This, taken from the USPTO website, lays out the restrictions:

"Anyone taking the registration examination is expressly prohibited from disclosing, publishing, reproducing, or transmitting the content, or substantially similar content, of the examination, in whole or in part, in any form or by any means, verbal or written, electronic or mechanical, for any purpose. Beginning April 2, 2013, at each test site, every applicant will be required to enter into a non-disclosure agreement as a condition to sitting for the examination."

In order to meet the needs of test takers, Wysebridge developed a comprehensive study suite of materials, that allows individuals to read short, concise, and focused summaries of the patent law updates. Along with this, Wysebridge released a database of practice questions, that is continually being updated, to allow individuals to test their comprehension of the AIA rules and regulations.

"I 100% feel these Wysebridge materials are worth the price, especially considering what your other options are," said one test taker who passed the exam using Wysebridge Patent Bar Reviews materials. "I had already spent over $3,000 on other study materials and failed, and wish I had found Wysebridge from the onset. These resources are indispensable for passing the exam...and the AIA materials are amazing."

You can follow Wysebridge Patent Bar Review using a variety of social media sites, including Twitter, Facebook, and LinkedIn. Stay updated on the latest tips, study suggestions, exam changes, and intellectual property updates.

About Wysebridge Patent Bar Review
Wysebridge Patent Bar Review is the industry leader in assisting individuals study for and pass the United States Patent Bar Exam. Formed in 2012, Wysebridge Patent Bar Review develops study resources and testing simulators for individuals preparing to take the Patent Bar Exam.

Read the full story at http://www.prweb.com/releases/2013/AIAStudyMaterials/prweb10670794.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. United States Patent and Trademark Office to Require Signed NDA Affects Many Reports Wysebridge
2. Up to the Challenge: Careers in Science in the Midst of Drastic Change, According to Wysebridge Patent Bar Review
3. Soaring School Costs and Vanishing Jobs Demands More From Lawyers; Wysebridge Suggests Becoming a Registered Patent Attorney
4. Wysebridge Reports 94% Success Rate for Passing the Patent Bar Exam
5. Wysebridge Patent Bar Review Discusses Major Changes To The Patent Bar Exam
6. Wysebridge Patent Bar Review Announces the Launch of News Blog
7. The 2013 CES: Patents, Legislation Reform, and the Growing Market for Patent Attorneys and Agents Reviewed by Wysebridge
8. Wysebridge Encourages Taking The Patent Bar Before Major Exam Changes Are Implemented
9. The Fiscal Cliff Package: Wysebridge Offers Discounts
10. Growing Job-Market Niche Inside The Economic Decline: A Wysebridge Review
11. Wysebridge Launches Patent Bar Exam Study Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... (PRWEB) , ... December 02, ... ... (ETC), a consortium of pharmaceutical and biotechnology companies dedicated to collaboratively developing ... companies interested in supplying a vendor-supported, portable online UHPLC, with robust, probe-based ...
(Date:12/2/2016)... , December 2, 2016 The ... 2021, growing at a CAGR of 7.3% during the forecast period ... hospitals and diagnostic laboratories segment accounted for the largest share of ... ... report on global immunohistochemistry (IHC) market spread across 225 pages, profiling ...
(Date:11/30/2016)... 30, 2016  GenomOncology today announced the appointment of ... Affairs.  Dr. Coleman will oversee clinical content ... knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists with ... and clinical decision support, from quality control through reporting. ... , , ...
(Date:11/30/2016)... 2016 Biotest Pharmaceuticals Corporation (BPC), a leading ... the addition of its newest plasma collection center located ... . The 15,200 square foot state-of-the-art facility officially opened ... brings the total number of BPC,s plasma collection centers ... BPC,s Chief Executive Officer said "We are pleased to ...
Breaking Biology Technology:
(Date:11/24/2016)... -- Cercacor today introduced Ember TM Sport Premium ... measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion Index, ... approximately 30 seconds. Smaller than a smartphone, using only ... key data about their bodies to help monitor these ... Hemoglobin carries oxygen to muscles. When hemoglobin and ...
(Date:11/19/2016)... Securus Technologies, a leading provider of civil ... corrections and monitoring, announced today that it has offered ... an independent technology judge determine who has the largest ... telephone calling platform, and the best customer service. ... of what we do – which clearly is not ...
(Date:11/15/2016)... ROCKVILLE, Md. , Nov. 15, 2016 /PRNewswire/ ... clinical company developing therapeutics focused on the gut ... public offering of 25,000,000 shares of its common ... its common stock at a price to the ... gross proceeds to Synthetic Biologics from the offering, ...
Breaking Biology News(10 mins):